ANVISA registration 10071770947Valid until May 11, 2036ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2)
ANVISA Registration Number: 10071770947ABBOTT DIAGNOSTICOS RAPIDOS S.A.ABON BIOPHARM (HANGZHOU) CO LTDRisk Class IV
Device names
- Technical name
- ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2)
- Commercial name
- HIV 1/2 Human Immunodeficiency Virus Rapid Test Device
- Risk class
- Class IV
PT: ANTICORPO PARA VÍRUS DE IMUNODEFICIÊNCIA HUMANA TIPO 1 E TIPO 2 (HIV 1 E HIV 2)
Registration details
- Registration Number
- 10071770947
- Process Number
- 25351184727202548
- CNPJ
- 50248780000161
Company information
- Registration Holder
- ABBOTT DIAGNOSTICOS RAPIDOS S.A.
- Manufacturer
- ABON BIOPHARM (HANGZHOU) CO LTD
- Manufacturing Country
- China
PT: CHINA, REPÚBLICA POPULAR
Dates and status
- Publication Date
- May 11, 2026
- Validity
- 11/05/2036
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10071770947 and manufactured by ABON BIOPHARM (HANGZHOU) CO LTD. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until May 11, 2036.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.